Bullish Moving Averages
4
Bearish Moving Averages
12
Back Stocks profile
Stock analysis tool for investors
Performance
Open Price
50.00Prev. Close
48.0000Volume
42750.00Value
2137500.00Fundamentals
Market Cap Cr
84.10
Price to Earnings
0.00
Price to Book Value
2.70
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM Cr
0.00
Net Profit TTM Cr
0.00
Cash From Operating Activity Cr
0.33
Return on Equity %
1.86
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
94.7
Week
95
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
50.10
PIVOT
First Resistance
50.30
Second Resistance
50.60
Third Resistance
50.80
First Support
49.80
Second Support
49.60
Third Support
49.30
Relative Strength Index
49.04
Money Flow Index
2.81
MACD
0.32
MACD Signal
0.13
Average True Range
4.93
Average Directional Index
10.15
Rate of Change (21)
11.86
Rate of Change (125)
45.14
Commodity Channel Index
-3.3
Williams %R
-65.7
BETA
1 Month
1.71
3 Month
1.42
1 Year
3 Year
PRICE CHANGE ANALYSIS
↓ -0.26%
1 Week
Low
High
49
56.7
↓ -9.26%
1 Month
Low
High
46.5
56.7
↑ 1.01%
3 Months
Low
High
40.23
57.1
↓ -5.91%
6 Months
Low
High
40.23
58.5
↑ 8.46%
1 Year
Low
High
40.23
60.79
28 May 2024
Achyut Healthcare Ltd - 543499 - Audited Standalone Financial Results For The Half Year And Year Ended 31St March, 2024
Audited Standalone Financial Result for the Half year and Year ended 31st March, 2024
28 May 2024
Achyut Healthcare Ltd - 543499 - Board Meeting Outcome for Audited Standalone Financial Results For The Half Year And Year Ended 31St March, 2024
Audited Standalone Financial Results for the Half year and Year ended 31st March, 2024
20 May 2024
Achyut Healthcare Ltd - 543499 - Board Meeting Intimation for Board Meeting Intimation For Board Meeting To Be Held On Tuesday 28Th May, 2024.
Achyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve This is to inform you under Regulation 29 and any other Regulation of SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015, a Meeting of the Board of Directors of the Company will be held on Tuesday, 28th May, 2024 at the Registered Office of the Company to transact following business; 1. To consider and approve the Audited financial results and Audit Report there on of the Company for the half year and year ended on 31st March, 2024. 2. To consider and approve the related party transactions disclosure under regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements), 2015 for the half year ended 31st March, 2024. 3. To Appoint M/s. Kamlesh M. Shah & Co., Company Secretaries as Secretarial Auditor of the Company for the F.Y. 2024-25. 4. To appoint M/s. Mohta Khetawat & Co., having Membership No. 164122 and FRN No. 140845W, Chartered Accountants as an internal auditor of the Company for the F.Y. 2024-25.
08 May 2024
Achyut Healthcare Ltd - 543499 - Submission Of Statement Of Deviation Or Variation For Proceeds Of Public Issue Pursuant To Regulation 32 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Submission of statement of Deviation or variation for proceeds of public issue pursuant to Regulation 32 of the SEBI (LODR) Regulation, 2015 fort the half year ended on 31st March, 2024.
12 Apr 2024
Achyut Healthcare Ltd - 543499 - Compliance Certificate - Regulation 7 (3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015. For The Year 01/04/2023 To 31/03/2024
Compliance certificate- Regulation 7(3) of Secutities and Exchange Board of India (LODR) Regulation, 2015 for the Financial year ended 31.03.2024
11 Apr 2024
Achyut Healthcare Ltd - 543499 - Submission Of Share Transfer Etc. Certificate For The Year Ended 31St March 2024, Pursuant To Regulation 40(10) Of The SEBI (LODR ) 2015.
Submission of Share Transfer etc. Certificate for the year ended 31st March, 2024, pursuant to Regulation 40(10) of the SEBI (LODR), 2015.
11 Apr 2024
Achyut Healthcare Ltd - 543499 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAchyut Healthcare Ltd 2CIN NO.L67120GJ1996PLC028600 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Drashti Unadkat Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Jigen J modi Designation: Managing Director and Cheif Financial Officer EmailId: [email protected] Date: 11/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
11 Apr 2024
Achyut Healthcare Ltd - 543499 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI DP Regulation for the quarter ended 31st March, 2024.
29 Mar 2024
Achyut Healthcare Ltd - 543499 - Closure of Trading Window
Intimation for Trading Windows Closure-Pursuant to closure of 4th Quarter and year ended F.Y. 2023-24 ending on 31.03.2024
22 Feb 2024
Achyut Healthcare Ltd - 543499 - Intimation On Approval Received From BSE Limited For Listing Of 28,08,000 Equity Shares Issued On Preferential Basis To Non Promoters
Intimation on approval received from BSE Limited for listing of 28,08,000 equity shares issued on preferential basis to non promoters.
